Biogen Sues Over 'Copycat' Alzheimer Treatment Products
Biogen Inc. hit a New York biotech company with a patent and trademark infringement suit Wednesday, alleging it is selling "copycat" products similar to a therapeutic antibody Biogen is developing to...To view the full article, register now.
Already a subscriber? Click here to view full article